Pyloric distensibility measurement predicts symptomatic response to intrapyloric botulinum toxin injection

Charlotte Desprez (1) , Chloé Melchior (1, 2, 3, 4) , Fabien Wuestenberghs (2, 3, 4) , Alberto Zalar (1) , Jeremie Jacques (5) , Anne-Marie Leroi (6, 2, 3, 4, 7) , Guillaume Gourcerol (6, 2, 3, 4)

1 Service d'Hépato-Gastroentérologie [CHU Rouen]
2 ADEN - Nutrition, inflammation et dysfonctionnement de l'axe intestin-cerveau
3 IRIB - Institute for Research and Innovation in Biomedicine
4 UNIROUEN UFR Santé - UNIROUEN - UFR Santé
5 Service d'Hépato-Gastro-Entérologie et Nutrition [CHU Limoges]
6 Service de physiologie digestive, urinaire, respiratoire et de l'exercice [CHU Rouen]
7 CIC Rouen - Centre d'Investigation Clinique [CHU Rouen]

Domains: Life Sciences [q-bio]; Human health and pathology; Hépatology and Gastroenterology

Charlotte Desprez, Chloé Melchior, Fabien Wuestenberghs, Alberto Zalar, Jeremie Jacques, et al.. Pyloric distensibility measurement predicts symptomatic response to intrapyloric botulinum toxin injection. Gastrointestinal Endoscopy, 2019, 90 (5), pp.754-760.e1. ⟨10.1016/j.gie.2019.04.228⟩. ⟨hal-02363988⟩